Rittenberg Cynthia N
Clin J Oncol Nurs. 2002 Mar-Apr;6(2):103-4. doi: 10.1188/02.CJON.103-104.
This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.
本文综述了一类新型的止吐药,即神经激肽-1(NK-1)受体拮抗剂(RAs)。一种NK-1 RA——阿瑞匹坦的临床试验正在进行中。